crypto vs bank Featured

Afternoon comment: Suddenly rising, what is the reason?Today, two medical funds will be invested, namely, 800 yuan Nazhi Biotechnology (017895) and 800 yuan Fuguo Medical (018209), and 1000 yuan A-share consumption base (005970). I am a long-term consumer of medical care, and I have performed well in the past two days. Next year, the consumption subsidy policy will not be small, and the medical valuation is cheap, which is worthy of layout, just need more patience. Everybody keep up.Today, I voted for 1000 yuan Fuguo A500 Index (022464), and the current income is 1%. When the market comes, I will buy the A500 index to quickly increase my position. On the 15th, the personal pension will also include A500 in the investable fund range, and there will be another wave of incremental funds. My current thinking is to broaden the base, balance the allocation of science and technology, medical care and consumption, and not fall. If the market turns fast, it will suddenly rise, and I will stick to the position.

Afternoon comment: Suddenly rising, what is the reason?Afternoon comment: Suddenly rising, what is the reason?Today, two medical funds will be invested, namely, 800 yuan Nazhi Biotechnology (017895) and 800 yuan Fuguo Medical (018209), and 1000 yuan A-share consumption base (005970). I am a long-term consumer of medical care, and I have performed well in the past two days. Next year, the consumption subsidy policy will not be small, and the medical valuation is cheap, which is worthy of layout, just need more patience. Everybody keep up.

Today, two medical funds will be invested, namely, 800 yuan Nazhi Biotechnology (017895) and 800 yuan Fuguo Medical (018209), and 1000 yuan A-share consumption base (005970). I am a long-term consumer of medical care, and I have performed well in the past two days. Next year, the consumption subsidy policy will not be small, and the medical valuation is cheap, which is worthy of layout, just need more patience. Everybody keep up.Today, two medical funds will be invested, namely, 800 yuan Nazhi Biotechnology (017895) and 800 yuan Fuguo Medical (018209), and 1000 yuan A-share consumption base (005970). I am a long-term consumer of medical care, and I have performed well in the past two days. Next year, the consumption subsidy policy will not be small, and the medical valuation is cheap, which is worthy of layout, just need more patience. Everybody keep up.Today, I bought the 1000 yuan CEIBS Robot Index (020256) on dips, and it rose sharply after opening a position last week. At present, the income is 2.89%, and it has been adjusted for two consecutive days, and I continued to add positions on dips. At present, the position is a bit low. Robots should be one of the main lines of the New Year's market, which continues to be good for catalysis. Tesla, the general leader, rose sharply last night, which gave a boost to the market of A-share robots. The New Year's market generally has 10 times as many shares, so the room for robots to rise is not small, and it is suitable for eating meat.